Should UK patients expect to access innovative medicines on the NHS?

As pressures on the NHS continue to intensify, should patients still expect timely access to the latest innovative treatments or is that promise becoming harder to keep? This panel of strategic, system leaders will explore what enables equitable and timely access to innovation, what trade offs stand in the way, and how the NHS, industry and patients can work differently to ensure innovation delivers for the UK population. CP-573470 | April 2026 This session is sponsored by Johnson & Johnson.